Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
61,778,278
-
Total 13F shares
-
13,081,587
-
Share change
-
+13,081,587
-
Total reported value
-
$220,131,000
-
Price per share
-
$16.98
-
Number of holders
-
32
-
Value change
-
+$220,131,076
-
Number of buys
-
32
Institutional Holders of Aura Biosciences, Inc. - Common Stock (AURA) as of Q4 2021
As of 31 Dec 2021,
Aura Biosciences, Inc. - Common Stock (AURA) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,081,587 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, Medicxi Ventures Management (Jersey) Ltd, CITADEL ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and Nantahala Capital Management, LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.